Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Post-Colposcopy Management and Progression Predictors of Biopsy-Proven CIN1 in Women Under 25 Years.

Loopik DL, Bekkers RLM, Massuger LFAG, Melchers WJG, Siebers AG, Bentley JR.

J Obstet Gynaecol Can. 2019 Mar;41(3):292-299. doi: 10.1016/j.jogc.2018.06.021. Epub 2018 Oct 27.

PMID:
30786980
2.

European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects.

Keppens C, Dufraing K, van Krieken HJ, Siebers AG, Kafatos G, Lowe K, Demonty G, Dequeker EMC.

Virchows Arch. 2019 Jul;475(1):25-37. doi: 10.1007/s00428-019-02525-9. Epub 2019 Feb 5.

3.

Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy.

Aitken CA, Siebers AG, Matthijsse SM, Jansen EEL, Bekkers RLM, Becker JH, Ter Harmsel B, Roovers JWR, van Kemenade FJ, de Kok IMCM.

Acta Obstet Gynecol Scand. 2019 Jun;98(6):737-746. doi: 10.1111/aogs.13547. Epub 2019 Feb 27.

4.

Incidence and groups at risk for unexpected uterine leiomyosarcoma: a Dutch nationwide cohort study.

van den Haak L, de Kroon CD, Warmerdam MI, Siebers AG, Rhemrev JP, Nieboer TE, Jansen FW.

Arch Gynecol Obstet. 2019 Jan;299(1):159-165. doi: 10.1007/s00404-018-4949-4. Epub 2018 Nov 30.

5.

Justifying conservative management of CIN2 in women younger than 25 years - A population-based study.

Loopik DL, Bekkers RLM, Massuger LFAG, Melchers WJG, Siebers AG, Bentley J.

Gynecol Oncol. 2019 Jan;152(1):82-86. doi: 10.1016/j.ygyno.2018.10.038. Epub 2018 Nov 7.

PMID:
30413339
6.

Screening for persistent high-risk HPV infections may be a valuable screening method for young women; A retrospective cohort study.

Ebisch RMF, Ketelaars PJW, van der Sanden WMH, Schmeink CE, Lenselink CH, Siebers AG, Massuger LFAG, Melchers WJG, Bekkers RLM.

PLoS One. 2018 Oct 24;13(10):e0206219. doi: 10.1371/journal.pone.0206219. eCollection 2018.

7.

Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more.

Siebers AG, van der Linden H, Vedder JEM, Bekkers RLM, Melchers WLG, Bulten J.

Cytopathology. 2018 Jun;29(3):275-280. doi: 10.1111/cyt.12536. Epub 2018 Mar 25.

PMID:
29575519
8.

Low Light Availability Alters Root Exudation and Reduces Putative Beneficial Microorganisms in Seagrass Roots.

Martin BC, Gleeson D, Statton J, Siebers AR, Grierson P, Ryan MH, Kendrick GA.

Front Microbiol. 2018 Jan 11;8:2667. doi: 10.3389/fmicb.2017.02667. eCollection 2017.

9.

RAS testing for colorectal cancer patients is reliable in European laboratories that pass external quality assessment.

Tack V, Ligtenberg MJL, Siebers AG, Rombout PDM, Dabir PD, Weren RDA, van Krieken JHJM, Dequeker EMC.

Virchows Arch. 2018 May;472(5):717-725. doi: 10.1007/s00428-017-2291-z. Epub 2018 Jan 15.

PMID:
29333594
10.

High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.

Ketelaars PJW, Bosgraaf RP, Siebers AG, Massuger LFAG, van der Linden JC, Wauters CAP, Rahamat-Langendoen JC, van den Brule AJC, IntHout J, Melchers WJG, Bekkers RLM.

Prev Med. 2017 Aug;101:96-101. doi: 10.1016/j.ypmed.2017.05.021. Epub 2017 Jun 1.

11.

Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.

Ebisch RMF, Rutten DWE, IntHout J, Melchers WJG, Massuger LFAG, Bulten J, Bekkers RLM, Siebers AG.

J Clin Oncol. 2017 Aug 1;35(22):2542-2550. doi: 10.1200/JCO.2016.71.4543. Epub 2017 May 25.

PMID:
28541790
12.

Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.

Ebisch RM, van der Horst J, Hermsen M, Rijstenberg LL, Vedder JE, Bulten J, Bosgraaf RP, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Massuger LF, Melchers WJ, Bekkers RL, Siebers AG.

Mod Pathol. 2017 Jul;30(7):1021-1031. doi: 10.1038/modpathol.2017.16. Epub 2017 Mar 17.

13.

Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.

van der Horst J, Siebers AG, Bulten J, Massuger LF, de Kok IM.

Cancer Med. 2017 Feb;6(2):416-423. doi: 10.1002/cam4.971. Epub 2017 Jan 19.

14.

Long-term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsy.

Visser NC, Sparidaens EM, van den Brink JW, Breijer MC, Boss EA, Veersema S, Siebers AG, Bulten J, Pijnenborg JM, Bekkers RL.

Acta Obstet Gynecol Scand. 2016 Dec;95(12):1418-1424. doi: 10.1111/aogs.13022. Epub 2016 Oct 14.

15.

Triage of high-risk HPV positive women in cervical cancer screening.

Ebisch RM, Siebers AG, Bosgraaf RP, Massuger LF, Bekkers RL, Melchers WJ.

Expert Rev Anticancer Ther. 2016 Oct;16(10):1073-85. doi: 10.1080/14737140.2016.1232166. Epub 2016 Sep 12. Review.

PMID:
27598683
16.

Adnexal masses in children, adolescents and women of reproductive age in the Netherlands: A nationwide population-based cohort study.

Hermans AJ, Kluivers KB, Janssen LM, Siebers AG, Wijnen MHWA, Bulten J, Massuger LFAG, Coppus SFPJ.

Gynecol Oncol. 2016 Oct;143(1):93-97. doi: 10.1016/j.ygyno.2016.07.096. Epub 2016 Jul 12.

PMID:
27421754
17.

How we do: optimizing bone marrow biopsy logistics for sign-out within 2 days.

de Laak-de Vries I, Siebers AG, Burgers L, Diepenbroek C, Link M, Groenen P, van Krieken JH, Hebeda KM.

J Hematop. 2016 Mar 5;9(2):67-71. eCollection 2016 Jun.

18.

The value of fine needle aspiration cytology diagnosis in ovarian masses in children and adolescents.

Hermans AJ, Kluivers KB, Siebers AG, Wijnen MH, Bulten J, Massuger LF, Coppus SF.

Hum Reprod. 2016 Jun;31(6):1236-40. doi: 10.1093/humrep/dew072. Epub 2016 Apr 10.

PMID:
27067508
19.

The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.

Ebisch RM, de Kuyper-de Ridder GM, Bosgraaf RP, Massuger LF, IntHout J, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Bulten J, Siebers AG, Bekkers RL, Melchers WJ.

Int J Cancer. 2016 Aug 1;139(3):691-9. doi: 10.1002/ijc.30090. Epub 2016 Apr 7.

20.

Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study.

Eysbouts YK, Bulten J, Ottevanger PB, Thomas CM, Ten Kate-Booij MJ, van Herwaarden AE, Siebers AG, Sweep FC, Massuger LF.

Gynecol Oncol. 2016 Jan;140(1):70-5. doi: 10.1016/j.ygyno.2015.11.014. Epub 2015 Nov 14.

PMID:
26586414
21.

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates.

Rozemeijer K, Penning C, Siebers AG, Naber SK, Matthijsse SM, van Ballegooijen M, van Kemenade FJ, de Kok IM.

Cancer Causes Control. 2016 Jan;27(1):15-25. doi: 10.1007/s10552-015-0678-1. Epub 2015 Oct 12.

22.

Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.

Goetze K, Fabian CG, Siebers A, Binz L, Faber D, Indraccolo S, Nardo G, Sattler UG, Mueller-Klieser W.

Cell Oncol (Dordr). 2015 Oct;38(5):377-85. doi: 10.1007/s13402-015-0237-5. Epub 2015 Aug 19.

PMID:
26288178
23.

Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study.

Siebers AG, Arbyn M, Melchers WJ, van Kemenade FJ, Vedder JE, van der Linden H, van Ballegooijen M, Bekkers RL, Bulten J.

Cancer Causes Control. 2014 Sep;25(9):1141-9. doi: 10.1007/s10552-014-0414-2. Epub 2014 Jun 17.

PMID:
24935226
24.

Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening.

Bosgraaf RP, Verhoef VM, Massuger LF, Siebers AG, Bulten J, de Kuyper-de Ridder GM, Meijer CJ, Snijders PJ, Heideman DA, IntHout J, van Kemenade FJ, Melchers WJ, Bekkers RL.

Int J Cancer. 2015 Feb 1;136(3):646-55. doi: 10.1002/ijc.29026. Epub 2014 Jun 26.

25.

The current position and the future perspectives of cervical cancer screening.

Bosgraaf RP, Siebers AG, De Hullu JA, Massuger LF, Bulten J, Bekkers RL, Melchers WJ.

Expert Rev Anticancer Ther. 2014 Jan;14(1):75-92. doi: 10.1586/14737140.2014.856273. Epub 2013 Nov 28. Review.

PMID:
24308681
26.

Cervical cytology in serous and endometrioid endometrial cancer.

Roelofsen T, Geels YP, Pijnenborg JM, van Ham MA, Zomer SF, van Tilburg JM, Snijders MP, Siebers AG, Bulten J, Massuger LF.

Int J Gynecol Pathol. 2013 Jul;32(4):390-8. doi: 10.1097/PGP.0b013e31826a62bb.

PMID:
23722512
27.

European consensus conference for external quality assessment in molecular pathology.

van Krieken JH, Siebers AG, Normanno N; Quality Assurance for Molecular Pathology group.

Ann Oncol. 2013 Aug;24(8):1958-63. doi: 10.1093/annonc/mdt153. Epub 2013 Apr 23. Review.

PMID:
23613479
28.

Guideline on the requirements of external quality assessment programs in molecular pathology.

van Krieken JH, Normanno N, Blackhall F, Boone E, Botti G, Carneiro F, Celik I, Ciardiello F, Cree IA, Deans ZC, Edsjö A, Groenen PJ, Kamarainen O, Kreipe HH, Ligtenberg MJ, Marchetti A, Murray S, Opdam FJ, Patterson SD, Patton S, Pinto C, Rouleau E, Schuuring E, Sterck S, Taron M, Tejpar S, Timens W, Thunnissen E, van de Ven PM, Siebers AG, Dequeker E.

Virchows Arch. 2013 Jan;462(1):27-37. doi: 10.1007/s00428-012-1354-4. Epub 2012 Dec 19.

PMID:
23250354
29.

Accurate assessment of cell density in low cellular liquid-based cervical cytology.

Siebers AG, van der Laak JA, Huberts-Manders R, Vedder JE, Bulten J.

Cytopathology. 2013 Aug;24(4):216-21. doi: 10.1111/j.1365-2303.2012.00990.x. Epub 2012 Jun 19.

PMID:
22708685
30.

Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis.

de Bekker-Grob EW, de Kok IM, Bulten J, van Rosmalen J, Vedder JE, Arbyn M, Klinkhamer PJ, Siebers AG, van Ballegooijen M.

Cancer Causes Control. 2012 Aug;23(8):1323-31. doi: 10.1007/s10552-012-0011-1. Epub 2012 Jun 17.

PMID:
22706692
31.

Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology.

Siebers AG, Klinkhamer PJ, Vedder JE, Arbyn M, Bulten J.

Arch Pathol Lab Med. 2012 Jan;136(1):76-83. doi: 10.5858/arpa.2011-0113-OA.

PMID:
22208490
32.

Human papillomavirus persistence in young unscreened women, a prospective cohort study.

Schmeink CE, Melchers WJ, Siebers AG, Quint WG, Massuger LF, Bekkers RL.

PLoS One. 2011;6(11):e27937. doi: 10.1371/journal.pone.0027937. Epub 2011 Nov 23.

33.

The effect of modified constraint-induced movement therapy on spasticity and motor function of the affected arm in patients with chronic stroke.

Siebers A, Oberg U, Skargren E.

Physiother Can. 2010 Fall;62(4):388-96. doi: 10.3138/physio.62.4.388. Epub 2010 Oct 18.

34.

Patients with cervical cancer: why did screening not prevent these cases?

de Bie RP, Vergers-Spooren HC, Massuger LF, Siebers AG, Salet-van der Pol MR, Vedder JE, Melchers WJ, Bulten J, Bekkers RL.

Am J Obstet Gynecol. 2011 Jul;205(1):64.e1-7. doi: 10.1016/j.ajog.2011.02.046. Epub 2011 Feb 23.

PMID:
21481838
35.

Age-specific patterns of unsatisfactory results for conventional Pap smears and liquid-based cytology: data from two randomised clinical trials.

Castle PE, Bulten J, Confortini M, Klinkhamer P, Pellegrini A, Siebers AG, Ronco G, Arbyn M.

BJOG. 2010 Aug;117(9):1067-73. doi: 10.1111/j.1471-0528.2010.02650.x.

36.

Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial.

Siebers AG, Klinkhamer PJ, Grefte JM, Massuger LF, Vedder JE, Beijers-Broos A, Bulten J, Arbyn M.

JAMA. 2009 Oct 28;302(16):1757-64. doi: 10.1001/jama.2009.1569. Erratum in: JAMA. 2009 Dec 2;302(21):2322.

PMID:
19861667
37.

Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities.

de Bie RP, van de Nieuwenhof HP, Bekkers RL, Melchers WJ, Siebers AG, Bulten J, Massuger LF, de Hullu JA.

Br J Cancer. 2009 Jul 7;101(1):27-31. doi: 10.1038/sj.bjc.6605124. Epub 2009 Jun 9.

38.

Cytologic detection of cervical abnormalities using liquid-based compared with conventional cytology: a randomized controlled trial.

Siebers AG, Klinkhamer PJ, Arbyn M, Raifu AO, Massuger LF, Bulten J.

Obstet Gynecol. 2008 Dec;112(6):1327-34. doi: 10.1097/AOG.0b013e31818c2b20.

PMID:
19037043
39.

Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989-2003.

van de Nieuwenhof HP, Massuger LF, de Hullu JA, van Ham MA, van Dijck JA, Siebers AG, Bekkers RL.

Br J Cancer. 2008 Jan 15;98(1):165-7. doi: 10.1038/sj.bjc.6604118. Epub 2008 Jan 8.

40.

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J.

Obstet Gynecol. 2008 Jan;111(1):167-77. doi: 10.1097/01.AOG.0000296488.85807.b3. Review.

PMID:
18165406
41.

Objective assessment of cancer biomarkers using semi-rare event detection.

van der Laak JA, Siebers AG, Aalders SA, Grefte JM, de Wilde PC, Bulten J.

Cell Oncol. 2007;29(6):483-95.

42.

Referral compliance, outcome and predictors of CIN after repeated borderline cervical smears in the Netherlands.

Siebers AG, Massuger LF, Bulten J.

Cytopathology. 2007 Apr;18(2):96-104.

PMID:
17397494
43.

Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology.

Siebers AG, Verbeek AL, Massuger LF, Grefte JM, Bulten J.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1069-74.

PMID:
16803487
44.

Abnormal cervical cytology in women eligible for IVF.

van Hamont D, Nissen LH, Siebers AG, Hendriks JC, Melchers WJ, Kremer JA, Massuger LF.

Hum Reprod. 2006 Sep;21(9):2359-63. Epub 2006 May 9.

PMID:
16684844
45.
46.

Automated identification of diploid reference cells in cervical smears using image analysis.

van der Laak JA, Siebers AG, Cuijpers VM, Pahlplatz MM, de Wilde PC, Hanselaar AG.

Cytometry. 2002 Apr 1;47(4):256-64.

PMID:
11933016
48.

Loss of pathogenic potential after cloning of the low-passage Borrelia burgdorferi ZS7 tick isolate: a cautionary note.

Siebers A, Zhong W, Wallich R, Simon MM.

Med Microbiol Immunol. 1999 Dec;188(3):125-30.

PMID:
10776842
49.

Assembly of the Kdp complex, the multi-subunit K+-transport ATPase of Escherichia coli.

Gassel M, Siebers A, Epstein W, Altendorf K.

Biochim Biophys Acta. 1998 Dec 9;1415(1):77-84.

Supplemental Content

Loading ...
Support Center